Previous 10 | Next 10 |
BOSTON, March 16, 2022 (GLOBE NEWSWIRE) -- Radius Health, Inc. ("Radius" or the "Company") (Nasdaq: RDUS), today announced appointments to new roles on its executive leadership team, effective immediately. Mark Conley has joined Radius as the Company’s Chief Financial Officer. ...
Exclusive extension of research discovery collaboration with Mass General Hospital (MGH) Focus of the program: development of novel oral SIK inhibitors for musculoskeletal diseases Extension of activity is based on data from existing collaboration which generated nonclinical mol...
BOSTON, March 07, 2022 (GLOBE NEWSWIRE) -- Radius Health, Inc. (“Radius” or the “Company”) (NASDAQ: RDUS) today announced that Kelly Martin, CEO, has accepted an invitation to participate in a virtual fireside chat hosted by Mohit Bansal, Managing Director of Equ...
Focus: RAD011, our investigational synthetic cannabidiol oral solution Broad market interest in the underlying science, data, and clinical translation of the asset Goal: provide foundational review of the asset and progress since acquisition in December, 2020 BOSTON, March...
Radius Health (NASDAQ:RDUS) has filed a supplementary New Drug Application (sNDA) with the FDA for its osteoporosis injection Tymlos (abaloparatide) in men. The filing, submitted on Feb. 25, will have a 10-month review. The sNDA is supported by phase 3 ATOM study data showing the primary endp...
Filed sNDA with the FDA ahead of schedule on Friday, February 25, 2022 Filing based on the positive ATOM study data previously announced on October 18, 2021 There is a 10-month FDA review BOSTON, March 01, 2022 (GLOBE NEWSWIRE) -- Radius Health, Inc. (“Radius”...
Image source: The Motley Fool. Radius Health (NASDAQ: RDUS) Q4 2021 Earnings Call Feb 24, 2022 , 8:30 a.m. ET Operator Continue reading For further details see: Radius Health (RDUS) Q4 2021 Earnings Call Transcript
Radius Health, Inc. (RDUS) Q4 2021 Earnings Conference Call February 24, 2022 8:30 A.M. ET Company Participants Ethan Holdaway - Head of Investor Relations Kelly Martin - President and Chief Executive Officer Steve Helwig - Principal Finance and Accounting Officer Bob Valentine - Business Int...
Radius Health, Inc. has lost over half its value since the transdermal patch version of its approved osteoporosis therapy (TYMLOS) flunked a Phase 3 trial in December 2021. Its other late-stage asset (elacestrant) just passed a Phase 3 study for breast cancer, but revenue from it will...
The following slide deck was published by Radius Health, Inc. in conjunction with their 2022 Q4 earnings call. For further details see: Radius Health, Inc. 2022 Q4 - Results - Earnings Call Presentation
News, Short Squeeze, Breakout and More Instantly...
2024-07-19 10:10:00 ET July 19, 2024 (Investorideas.com Newswire) Investorideas.com , a global news source and expert investing resource, announces today's roundup of stocks to watch in the Biotech, Cleantech Sectors. The newest biotech companies are involved in blood disorder treat...
A look at the top 10 most actives in the United States Ocean Power Technologies Inc. (OPTT) rose 54.4% to $0.4264 on volume of 158,036,142 shares Versus Systems Inc. (VS) rose 73.5% to $2.29 on volume of 40,036,424 shares Tesla Inc. (TSLA) rose 5.3% to $220.97 on volume of 32,375,487 shar...
Ferrous, Nonferrous and Finished Steel Sales Volumes Up Sequentially Radius Board Declares Quarterly Dividend PORTLAND, Ore., July 02, 2024 (GLOBE NEWSWIRE) -- Radius Recycling, Inc. (NASDAQ: RDUS) today reported results for the third quarter of fiscal 2024 ended May 31, 2024. ...